Lajos Balogh (scientist)
![]() | A major contributor to this article appears to have a close connection with its subject. (September 2024) |
This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (August 2024) |
Lajos Balogh | |
---|---|
![]() | |
Born | Komádi, Hajdú-Bihar, Hungary | January 15, 1950
Citizenship | Hungarian-American |
Education | Ph.D., Kossuth Lajos University of the Sciences and the Art |
Alma mater | KLTE, Debrecen, Hungary |
Occupation(s) | Scientist, Editor |
Known for | Polymer chemistry, dendrimers, and nanomedicine |
Website | precisionnanomedicine |
Lajos Peter Balogh (born January 15, 1950, Hungary), mainly referred to as Lou Balogh, is a Hungarian-American scientist known for his research on polymers, dendrimer nanocomposites, and nanomedicine. Balogh is the editor-in-chief of Precision Nanomedicine (PRNANO). Based on his career-long citation numbers, he belongs to the World's Top 2% Scientists.
Early life and education
[edit]Balogh was born on January 15, 1950, in Komádi, Hajdú-Bihar County, Hungary. He studied chemistry at the Debreceni Vegyipari Technikum then at the Kossuth Lajos University from 1969 to 1974, earning his Ph.D. in 1983. In 1991, Balogh received an invitation from the University of Massachusetts Lowell and moved to the United States.
Career
[edit]Balogh joined UMass Lowell as a visiting professor in 1991. In 1996, he left for the Michigan Molecular Institute to research dendrimers, where he was a senior associate scientist in Donald Tomalia's group. From 1998 to 2018, Balogh worked as a professor at the University of Michigan Ann Arbor, Center for Biologic Nanotechnology, the University at Buffalo, and co-directed Nano-Biotechnology Center at the Roswell Park Comprehensive Cancer Center. As a visiting professor, he also taught at the Chinese Academy of Sciences, the Seoul National University, and the Semmelweis University.[1]
Balogh is one of the co-founders of the American Society for Nanomedicine (2008). He has been a board member of several expert organizations, e.g., the U.S. Technical Advisory Group to ISO TC229 on Nanotechnology (since 2005), the Scientific Committee of the CLINAM Summits[2] (since 2011), and numerous other National and International Steering Committees.
Between 2008 and 2016, Balogh, as editor-in-chief, took an upstart scientific journal (Nanomedicine: Nanotechnology, Biology, and Medicine, Elsevier) from 5 editors and no journal impact factor to 20 editors and JIF2014 =6.9, (5-year JIF=7.5). He increased the journal's readership to over 480,000 downloads per year. In 2017, Balogh initiated Manuscript Clinic, a platform that helped scientists and students publish their research results in nanomedicine and nanotechnology and promoted both nanoscience and scientific writing. In 2018, he founded Andover House, Inc.,[3] a not-for-profit online publishing company, and launched Precision Nanomedicine (PRNANO). He serves as the editor-in-chief of this scientists-owned, fully open-access and peer-reviewed international journal. PRNANO has been designated the official journal of the International Society for Nanomedicine and CLINAM, the European Society for Clinical Nanomedicine (Basel, Switzerland).
Personal
[edit]Balogh is married to Éva Kovács Balogh, a Hungarian American linguist. He has three children, Andrea, Péter, and Áki. Peter Balogh was the crew chief of the University of Michigan Solar car team's MomentUM, which won first place at the North American Solar Challenge in 2005 and now works in the maritime industry in Asia. Aki Balogh[4] is the Co-founder and President of MarketMuse[5] and Co-founder and CEO of DLC.link.[6]
Research work
[edit]Balogh discovered and pioneered dendrimer nanocomposites,[7] drug delivery platforms,[8] and co-invented new cancer treatments.[9] He is considered an international expert in nanomedicine and scholarly publications. He published 228 scientific papers in chemistry, physics, nanotechnology, and nanomedicine, gave over 230 invited lectures, and was awarded 12 patents. His publications have been cited over 10000 times (22 papers with more than 100 citations, 11 with more than 200 citations, and 2 cited over 1000 times;[10] h-index=42).[11] Balogh has been listed as belonging to the World's top 2% of Scientists.[12]
Achievements
[edit]Balogh is one of the five founders of the American Society for Nanomedicine. He serves on the U.S. Technical Advisory Group to ISO TC 229 Nanotechnology and on the Board of several international and U.S. national organizations. Some recent awards include a visiting professorship for Senior International Scientists at the Chinese Academy of Sciences, Beijing, the Korean Federation of Science and Technology Societies Brain Pool Program Award for Renowned Foreign Scientists to teach at Seoul National University, Seoul, Korea, and a Fulbright Teaching/Research Scholarship at Semmelweis University. Balogh is a member of the External Body of the Hungarian Academy of Sciences (since 2011).
Selected publications
[edit]Peer-reviewed publications
[edit]- Wolfgang Parak, Beatriz Pelaz, Christoph Alexiou, Ramon A. Alvarez-Puebla, Frauke Alves, Anne M. Andrews, Sumaira Ashraf, Lajos P. Balogh, et al., Diverse Applications of Nanomedicine, ACS Nano. ACS Nano, 2017, 11 (3), pp 2313–2381, DOI: 10.1021/acsnano.6b0604
- Kukowska-Latallo, Jolanta F. Kimberly A. Candido, Zhengyi Cao, Shraddha S. Nigavekar, Istvan J Majoros, Thommey P. Thomas, Lajos P. Balogh, Mohamed K. Khan and James R. Baker, Jr., Nanoparticle Targeting of Anticancer Drug Improves Therapeutic Response in Animal Model of Human Epithelial Cancer, Cancer Research 2005, 65, 5317-5324
- L. Balogh and Donald A. Tomalia: Poly(Amidoamine) Dendrimer-Templated Nanocomposites I. Synthesis of Zero-Valent Copper Nanoclusters; Journal of Am. Chem. Soc., 1998, 120, 7355-7356
- L Balogh, R Valluzzi, KS Laverdure, SP Gido, GL Hagnauer, DA Tomalia: Formation of silver and gold dendrimer nanocomposites, Journal of Nanoparticle Research 1, 353-368
- Lajos P. Balogh, Shawn M. Redmond, Peter Balogh, Houxiang Tang, David C. Martin, Stephen C. Rand: "Self-Assembly and Optical Properties of Dendrimer Nanocomposite Multilayers," Macromolecular Bioscience 2007, 7, 1032–1046
- Yuliang Zhao, Lajos Balogh, Caging Cancer, Nanomedicine: Nanotechnology, Biology, and Medicine, 11 (2015) 867–869
- Hong, S. A. U. Bielinska, A. Mecke, B. Keszler, J. L. Beals, X. Shi, L. Balogh, B. G. Orr, J. R. Baker Jr., and M. M. Banaszak Holl, Interaction of Poly(amidoamine) Dendrimers with Supported Lipid Bilayers and Cells: Hole Formation and the Relation to Transport, Bioconj. Chem. 2004, 15, 774-782
- L Balogh, DR Swanson, DA Tomalia, GL Hagnauer, AT McManus, Dendrimer−silver complexes and nanocomposites as antimicrobial agents, Nano letters 1 (1), 18-21
Books
[edit]- Lajos P. Balogh (Ed), Nanomedicine's Most Cited Series, Vol.2, Nano-Enabled Medical Applications (Taylor & Francis, 2020)
- Lajos P. Balogh (Ed), Nanomedicine's Most Cited Series, Vol.1, Nanomedicine in Cancer (Taylor & Francis, 2017)
Book chapters
[edit]- Lajos P. Balogh, "Introduction to Nanomedicine" Chapter 1 in Nanomedicine in Health And Disease, Ed: Victor R. Preedy, Science Publishers, 2011, p.3.
- Lajos P. Balogh, Donald A. Mager and Mohamed K. Khan, "Synthesis and Biodisposition of Dendrimer Composite Nanoparticles," Chapter 6 in: Materials for Nanomedicine, Eds: V. Torchilin and M. Amiji, World Scientific Publishing, 2010
- Lajos P. Balogh, Teyeb Ould Ely, and Wojciech G. Lesniak "Composite Nanoparticles for Cancer Imaging and Therapy: Engineering Surface, Composition, and Shape," Chapter 4 in Nanomedicine Design of Particles, Sensors, Motors, Implants, Robots, and Devices, Eds: M. Schulz, V.N. Shanov, ISBN 978-1-59693-279-1, Artech House 2009
- Lajos P. Balogh, "Dendrimer 101" Chapter 11 (p 136-155) in: "Biological and Biomedical Applications of Engineered Nanostructures" Ed: Warren P. Chan – U. Toronto, Eurekah, 2007.
- Lajos P Balogh and Mohamed K Khan: Dendrimer Nanocomposites for Cancer Therapy" Chapter 28 (p. 551–592, in Nanotechnology in Cancer Therapy (Ed: Mansour Amiji), CRC Press (Taylor and Francis Group), Boca Raton, London, New York, 2006
Selected patents
[edit]- J. Y. Ye, T. B. Norris, L. P. Balogh, J. R. Baker, Jr., Laser-based Method and System for Enhancing Optical Breakdown, US 7,474,919 B2, January 6, 2009
- D. A. Tomalia and L. Balogh: "Nanocomposites of Dendritic Polymers" US 6,664,315 B2, December 16, 2003
- D. A. Tomalia and L. Balogh: "Method and Articles for Transfection of Genetic Material," US 6,475,994, November 5, 2002,
- L. Balogh, D. R. Swanson, D. A. Tomalia, G. L. Hagnauer, A. T. McManus: "Antimicrobial Dendrimer Nanocomposites and a Method of Treating Wounds," US 6,224,898 B1, May 1, 2001.
- R. Faust and L. Balogh: U.S. 5,665,837 (1997); Initiation via Haloboration in Living Cationic Polymerization
References
[edit]- ^ Macdonald, Steph (2019-05-10). "Weekly digest: what's happening in open science?". Open Pharma - Innovations in medical publishing. Retrieved 2024-08-12.
- ^ Löffler, Beat (2020-02-11). "11 Years of CLINAM, the European Foundation for Clinical Nanomedicine". Precision Nanomedicine. 3 (1): 483–486. doi:10.33218/001c.11897.
- ^ "Andover House Inc".
- ^ https://www.linkedin.com/in/akibalogh/
- ^ https://www.marketmuse.com/
- ^ https://www.dlcbtc.com/
- ^ Balogh, Lajos; Tomalia, Donald A. (1998-07-01). "Poly(Amidoamine) Dendrimer-Templated Nanocomposites. 1. Synthesis of Zerovalent Copper Nanoclusters". Journal of the American Chemical Society. 120 (29): 7355–7356. doi:10.1021/ja980861w. ISSN 0002-7863.
- ^ Balogh, Lajos; Tomalia, Donald (July 9, 1998). "Poly(Amidoamine) Dendrimer-Templated Nanocomposites I. Synthesis of Zero-Valent Copper Nanoclusters". J. Am. Chem. Soc. 120 (29): 7355–7356. doi:10.1021/ja980861w.
- ^ Khan, Mohamed K.; Minc, Leah D.; Nigavekar, Shraddha S.; Kariapper, Muhammed S. T.; Nair, Bindu M.; Schipper, Matthew; Cook, Andrew C.; Lesniak, Wojciech G.; Balogh, Lajos P. (2008-03-01). "Fabrication of {198Au0} radioactive composite nanodevices and their use for nanobrachytherapy". Nanomedicine: Nanotechnology, Biology, and Medicine. 4 (1): 57–69. doi:10.1016/j.nano.2007.11.005. ISSN 1549-9642. PMC 2396230. PMID 18249156.
- ^ Pelaz, Beatriz; Alexiouu, Christoph; Alvarez-Puebla, Ramon A.; Alves, Frauke; Andrews, Anne M.; Ashraf, Sumaira; Balogh, Lajos P; Ballerini, Laura; Bestetti, Alessandra; Brendel, Cornelia; Bosi, Susanna; Carril, Monica; Chen, Warren C.W.; Chen, Chunying; Chen, Xiaodong (2017). "Diverse Applications of Nanomedicine". ACS Nano. 11 (3): 2313–2381. doi:10.1021/acsnano.6b06040. ISSN 1936-0851. PMC 5371978. PMID 28290206.
- ^ "Google Scholar".
- ^ Ioannidis, John P. A.; Boyack, Kevin W.; Baas, Jeroen (2020). "Updated science-wide author databases of standardized citation indicators". PLOS Biology. 18 (10): e3000918. doi:10.1371/journal.pbio.3000918. PMC 7567353. PMID 33064726.
This article needs additional or more specific categories. (August 2024) |